Nuformix plc (LON:NFX – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as GBX 0.18 ($0.00) and last traded at GBX 0.21 ($0.00), with a volume of 322484 shares. The stock had previously closed at GBX 0.19 ($0.00).
Nuformix Trading Down 7.3 %
The stock’s fifty day moving average price is GBX 0.23 and its 200 day moving average price is GBX 0.28. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.51 and a quick ratio of 3.35. The stock has a market capitalization of £1.56 million, a P/E ratio of -1.63 and a beta of 0.29.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
See Also
- Five stocks we like better than Nuformix
- What is a Special Dividend?
- ASML Fires Warning Shot For Tech Investors
- The 3 Best Retail Stocks to Shop for in August
- Prologis Stock Leading U.S. Logistics Boom
- How to Calculate Return on Investment (ROI)
- Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
